Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

Answers from the Lab

Το περιεχόμενο παρέχεται από το Mayo Clinic Laboratories. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Mayo Clinic Laboratories ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

29d ago 10:53

MP3•Αρχική οθόνη επεισοδίου

Matthew Schultz, Ph.D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.

(00:31)
Would you share a little bit about yourself and your background?

(01:11)
Could you provide us with an overview of this particular peripheral neuropathy?

(03:09)
Can you share the background as to how your team learned about this condition and how you considered testing for it?

(04:42)

Would you explain what you saw when you performed the urine test on the first patient?

(05:26)
Were you able to test additional patients with this condition?

(06:09)

Could you expand on why this urine test is important?

(07:20)
How does a health care provider order urine testing for SORD deficiency?

(07:59)
How does this new SORD urine test complement the existing Mayo Clinic Laboratories test menu?

(08:55)

Could you summarize the benefits of ordering this SORD urine test at Mayo?

329 επεισόδια

#Science #Fitness #Medicine #Mayo Clinic Podcast For Laboratory #Laboratory Medicine #Healthcare #Lab #Mayo Clinic #Clinical #Dlmp #Morice #Pritt